Manojit Saha And Sohini Das

Stories by Manojit Saha And Sohini Das

Healthcare IPOs See A Surge In 2025

Healthcare IPOs See A Surge In 2025

Rediff.com   8 Jan 2026

The surge has come alongside a decline in average issue sizes and more muted listing-day returns compared with last year.

Tata Motors leads EV pack in 2025, but pecking order could change

Tata Motors leads EV pack in 2025, but pecking order could change

Rediff.com   8 Jan 2026

Mahindra and Mahindra (M&M) recorded the sharpest acceleration among large players, with EV retail jumping to 33,513 units from 7,139 units, an almost 5-fold jump, aided by strong demand for new launches.

Simple Energy debuts Gen 2 e-scooters to drive 2026 growth

Simple Energy debuts Gen 2 e-scooters to drive 2026 growth

Rediff.com   6 Jan 2026

'This is not just a cosmetic refresh,' said Suhas Rajkumar, founder and chief executive officer of Simple Energy. 'We have re-engineered the battery integration, made the scooter lighter, improved performance and expanded the portfolio so customers can choose based on real usage needs.'

Banks 'resilient' but face stiff fund mobilisation competition

Banks 'resilient' but face stiff fund mobilisation competition

Rediff.com   30 Dec 2025

The country's banking system, while remaining "resilient" with bad loans at over a decade low and strong capital buffers, will continue to face intense competition from non-bank sources for resource mobilisation, said the Reserve Bank of India's (RBI's) Trend and Progress of Banking in India 2024-25 report.

How RBI Governor Fared In The First Year

How RBI Governor Fared In The First Year

Rediff.com   29 Dec 2025

Sanjay Malhotra has made structural changes to banking regulation to bring down costs and increase efficiency. Plus, he kicked off a benign interest regime. But there are challenges ahead.

GST 2.0 boosts petrol-diesel car sales over EVs

GST 2.0 boosts petrol-diesel car sales over EVs

Rediff.com   10 Dec 2025

While GST on ICE vehicles was brought down significantly, for electric cars it remained at 5 per cent.

GST 2.0 Puts Luxury Cars In Fast Lane

GST 2.0 Puts Luxury Cars In Fast Lane

Rediff.com   10 Dec 2025

India's luxury auto market is rebounding after a slow start to 2025, with GST 2.0 emerging as the main catalyst.

50 Mn To 100 Mn Indians Suffer From Long Covid

50 Mn To 100 Mn Indians Suffer From Long Covid

Rediff.com   2 Dec 2025

Even by conservative assumptions that 5 to 10 per cent of infected individuals develop long Covid, India today may be home to 50 to 100 million infected individuals -- many silently coping with breathlessness, fatigue, palpitations, brain fog, or unexplained clotting tendencies.

RBI's policy dilemma: To look at inflation or growth for rate action

RBI's policy dilemma: To look at inflation or growth for rate action

Rediff.com   26 Nov 2025

The consumer price index (CPI)-based inflation hitting an all-time low in October would encourage the six-member monetary policy committee (MPC) of the Reserve Bank of India (RBI) to cut the policy repo rate in its upcoming December 3-5 meeting. However, the July-September GDP growth, expected to be above 7 per cent, may act as a deterrent.

Economy picked up steam in Oct on GST rejig, festival spends

Economy picked up steam in Oct on GST rejig, festival spends

Rediff.com   25 Nov 2025

Notwithstanding global headwinds, the Indian economy saw further momentum in October on the back of goods and services tax (GST) rate rationalisation and festival spending, as indicated by high-frequency indicators, the Reserve Bank of India's (RBI's) monthly State of the Economy report said.

Seniors to Drive 25% of India's Pharma

Seniors to Drive 25% of India's Pharma

Rediff.com   21 Nov 2025

'Once the 60-plus population hits 20 to 30 per cent of the country, the demand for elderly-care treatments will surge -- cardiac, metabolic, neurological, and musculoskeletal medicines are going to dominate the market for the next several decades.'

Pune Firm Unveils Diabetes-Control Implant

Pune Firm Unveils Diabetes-Control Implant

Rediff.com   19 Nov 2025

This innovation works by stimulating our natural organs so that it can produce and maintain the insulin balance.

VinFast Outsells Tesla in Festival Season But BYD Is King

VinFast Outsells Tesla in Festival Season But BYD Is King

Rediff.com   10 Nov 2025

Vinfast sold 137 cars versus Tesla's 109 during the festive months of September and October, as BYD maintained a strong lead with over 1,100 cars sold, according to Fada data.

USFDA's new draft biosimilar rules to benefit Indian biotech cos

USFDA's new draft biosimilar rules to benefit Indian biotech cos

Rediff.com   9 Nov 2025

The US Food and Drug Administration's (USFDA)'s new draft guidelines aimed at speeding up and reducing the cost of developing biosimilars - lower-priced, near-replicas of complex biologic medicines - could significantly benefit Indian biotech companies.

Bajaj Auto posts highest ever quarterly revenue and PAT

Bajaj Auto posts highest ever quarterly revenue and PAT

Rediff.com   8 Nov 2025

Pune-based two-wheeler major Bajaj Auto posted its highest ever quarterly revenue and profit after tax (PAT) in Q2FY26. Even as consolidated revenues were up 18.8 per cent year-on-year (Y-o-Y) to Rs 15,734.7 crore, PAT zoomed 53.2 per cent to Rs 2,122 crore.

Banks may not require RBI nod for floating arms

Banks may not require RBI nod for floating arms

Rediff.com   28 Oct 2025

For commercial banks to float subsidiaries, approval from the Reserve Bank of India (RBI) may not remain mandatory, according to highly placed sources.

'The Intent Is To Make A Better Bank In The Future'

'The Intent Is To Make A Better Bank In The Future'

Rediff.com   28 Oct 2025

'As the team builds, each of them will bring in a different perspective, new thinking.'

Where The Deadly Cough Syrup Was Made

Where The Deadly Cough Syrup Was Made

Rediff.com   18 Oct 2025

Sandwiched between a Hero MotoCorp showroom and a shop that hires out cooking utensils is a small, dingy building that's been locked up. The non-descript two-room building is a manufacturing unit of Sresan Pharmaceuticals, the pharma company made its Coldriff cough syrup that has allegedly killed 25 children in Madhya Pradesh.

RBI's Monetary Policy Committee sees scope for more rate cut

RBI's Monetary Policy Committee sees scope for more rate cut

Rediff.com   18 Oct 2025

Even if the Reserve Bank of India's Monetary Policy Committee decided to hold interest rates in the October meeting, it acknowledged the scope for further rate cuts while waiting for the impact of the past steps to play out.

Electric PV sales more than double in September; Tata Motors leads

Electric PV sales more than double in September; Tata Motors leads

Rediff.com   9 Oct 2025

Electric passenger vehicle (PV) retail sales jumped more than twofold in September with Tata Motors (TaMo) leading the pack having over 6,000 registrations and a 40 per cent market share.